Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Metastatic Melanoma
Interventions
BIOLOGICAL

Autologous tumor cells plus dendritic cells

A series of 8 vaccinations are administered over 6 months

DRUG

GM-CSF

500 mcg

Trial Locations (1)

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

All Listed Sponsors
lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00948480 - Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells | Biotech Hunter | Biotech Hunter